Megan Pelis to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Megan Pelis has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.017
-
Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res. 2009 Feb; 24(2):196-208.
Score: 0.017